Advertisement
<< Back To Blog Post
facebookPLUS...???

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

3 Comments

Jason Lockwood AKA Serviceman

First I would like to thank who ever mentioned HivPlusMen.com to you. However I am the founder of HivPlusMen.com. HIVPlusMen was created becuase of the disappointment of the internet in general. When I was diagnosed a year and a half ago I went online looking for a networking website for HIV + gay men and found not a single website. After some planning over a few months HIVPlusMen.com or HIVPositiveMen.com was born in mid September of 2008. If you would like a direct quote from the founder you can contact me at webmaster@hivplusmen.com . I do not make it a habit to spam blogs with this website. I am only trying to clear up some misunderstanding. Thanks for the plug in your blog. I was actually honored by the plug. Thank you, Jason Lockwod AKA Serviceman

October 16, 2008

David

RE: "NOT FUNNY" - I guess everyone as a different opinion...lol. But I wish MORE of the cash profits from the drugs where used to fund research and prevention. I DETEST sales reps in my doctor's office pinching the latest meds, and sticky notes and pens with Truvada or Kaletra logos on them. My doc reads med journals and goes to conferences, he doesn't need a sales rep to tell him what to give his patients. Prevention is key!

October 7, 2008

shoeboot

Thanks for the heads-up on the poz social site.....Your description of the NEW YORKER cartoon "NOT FUNNY", well for me, I thought it was Funny and maybe insightful. A reminder we are the valued consumers of Pharma Companies.....supply and demand ecomonics is funny and chilling. Shane

October 7, 2008

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.